Patent · US Active

Genes encoding a nystatin polyketide synthase and their manipulation and utility

US7851183B2 · kind B2 · utility

16Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2010
Grant dateDec 14, 2010
Priority date
Expiry dateMar 29, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P19/62
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides a nucleic acid molecule comprising: (a) a nucleotide sequence as shown in SEQ ID No. 35; or (b) a nucleotide sequence which is the complement of SEQ ID No. 35; or (c) a nucleotide sequence which is degenerate with SEQ ID No. 35; or (d) a nucleotide sequence hybridising under conditions of high stringency to SEQ ID No. 35, to the complement of SEQ ID No. 35, or to a hybridisation probe derived from SEQ ID No. 35 or the complement thereof; or (e) a nucleotide sequence having at least 80% sequence identity with SEQ ID No. 35; or (f) a nucleotide sequence having at least 65% sequence identity with SEQ ID No. 35 wherein said sequence preferably encodes or is complementary to a sequence encoding a nystatin PKS enzyme or a part thereof. Also provided are part of such molecules and polypeptides (and parts thereof) encoded by such a nucleic acid molecule, and the use of such molecules and polypeptides in facilitating nystatin biosynthesis and in the synthesis of nystatin derivatives and novel polyketide as macrolide structures.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.